Nexplanon (Etonogestrel)

Etonogestrel, the active ingredient in Nexplanon, is a progestin presented as a 68 mg subcutaneous implant for subcutaneous use. It provides long‑acting hormonal contraception by preventing ovulation and altering cervical mucus, and is indicated for women of reproductive age seeking reliable pregnancy prevention.

GNH USA supplies Nexplanon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support global distribution. Clients benefit from reliable supply chains, on‑time delivery, and dedicated technical support for product integration.

Etonogestrel, a progestin hormonal contraceptive, is used to prevent pregnancy.

- Contraception: provides long‑acting reversible birth control for women of reproductive age. - Family planning: reduces risk of unintended pregnancy through continuous hormone release. - Hormonal birth control: offers a three‑year implantable method that eliminates daily dosing.

Nexplanon may cause a range of adverse reactions.

Common Side Effects: - Irregular bleeding or amenorrhea: changes in menstrual pattern are frequent. - Headache: mild to moderate intensity reported. - Weight gain: modest increase observed in some users. - Breast tenderness: occasional discomfort.

Serious or Rare Side Effects: - Deep vein thrombosis: rare clot formation in veins. - Pulmonary embolism: serious clot that travels to lungs. - Severe allergic reaction: including rash, swelling, or anaphylaxis. - Infection at insertion site: may require medical attention. - Ectopic pregnancy: possible if contraceptive fails.

Before prescribing Nexplanon, clinicians should consider several safety measures.

- Screen for contraindications: assess history of thromboembolic disorders, liver disease, or hormone‑sensitive cancers. - Avoid use in pregnancy: product is intended to prevent pregnancy, not treat it. - Monitor menstrual changes: counsel patients about possible irregular bleeding. - Check insertion site: ensure proper placement and maintain aseptic technique. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Nexplanon can interact with other medicines that affect hormone metabolism.

Major Interactions (Avoid): - Enzyme inducers (e.g., rifampin, carbamazepine): may reduce contraceptive effectiveness. - Antifungal azoles (e.g., ketoconazole): may increase hormone levels and risk of side effects. - Protease inhibitor antiretrovirals: may alter etonogestrel plasma concentrations.

Moderate Interactions (Monitor Closely): - Certain antibiotics (e.g., tetracycline): may have minimal effect, monitor for breakthrough bleeding. - Herbal supplements (e.g., St. John’s wort): may decrease efficacy, advise caution.